Literature DB >> 33010069

Absence of R-Ras1 and R-Ras2 causes mitochondrial alterations that trigger axonal degeneration in a hypomyelinating disease model.

Berta Alcover-Sanchez1, Gonzalo Garcia-Martin1, Juan Escudero-Ramirez1, Carolina Gonzalez-Riano2, Paz Lorenzo2, Alfredo Gimenez-Cassina1, Laura Formentini1, Pedro de la Villa-Polo3,4, Marta P Pereira1, Francisco Wandosell1, Beatriz Cubelos1.   

Abstract

Fast synaptic transmission in vertebrates is critically dependent on myelin for insulation and metabolic support. Myelin is produced by oligodendrocytes (OLs) that maintain multilayered membrane compartments that wrap around axonal fibers. Alterations in myelination can therefore lead to severe pathologies such as multiple sclerosis. Given that hypomyelination disorders have complex etiologies, reproducing clinical symptoms of myelin diseases from a neurological perspective in animal models has been difficult. We recently reported that R-Ras1-/- and/or R-Ras2-/- mice, which lack GTPases essential for OL survival and differentiation processes, present different degrees of hypomyelination in the central nervous system with a compounded hypomyelination in double knockout (DKO) mice. Here, we discovered that the loss of R-Ras1 and/or R-Ras2 function is associated with aberrant myelinated axons with increased numbers of mitochondria, and a disrupted mitochondrial respiration that leads to increased reactive oxygen species levels. Consequently, aberrant myelinated axons are thinner with cytoskeletal phosphorylation patterns typical of axonal degeneration processes, characteristic of myelin diseases. Although we observed different levels of hypomyelination in a single mutant mouse, the combined loss of function in DKO mice lead to a compromised axonal integrity, triggering the loss of visual function. Our findings demonstrate that the loss of R-Ras function reproduces several characteristics of hypomyelinating diseases, and we therefore propose that R-Ras1-/- and R-Ras2-/- neurological models are valuable approaches for the study of these myelin pathologies.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  R-Ras; mitochondria; multiple sclerosis; myelin; neurodegeneration; oligodendrocyte

Mesh:

Year:  2020        PMID: 33010069     DOI: 10.1002/glia.23917

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  2 in total

Review 1.  Effects of Noonan Syndrome-Germline Mutations on Mitochondria and Energy Metabolism.

Authors:  Donald Bajia; Emanuela Bottani; Katarzyna Derwich
Journal:  Cells       Date:  2022-10-01       Impact factor: 7.666

2.  R-Ras1 and R-Ras2 Expression in Anatomical Regions and Cell Types of the Central Nervous System.

Authors:  Gonzalo Garcia-Martin; Miriam Sanz-Rodriguez; Berta Alcover-Sanchez; Marta P Pereira; Francisco Wandosell; Beatriz Cubelos
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.